Venetoclax-Based Regimens in CLL: Immunoglobulin G Levels, Absolute Neutrophil Counts, and Infectious Complications

<b>Background:</b> Chronic lymphocytic leukemia (CLL) is a prevalent hematologic malignancy that predominantly affects elderly individuals, posing significant clinical challenges due to patient comorbidities and inherent resistance to conventional chemotherapy. The emergence of targeted therapies co...

詳細記述

書誌詳細

主要な著者:	Wojciech Szlasa, Monika Kisielewska, Anna Sobczyńska-Konefał, Emilia Jaskuła, Monika Mordak-Domagała, Jacek Kwiatkowski, Katarzyna Tatara, Agnieszka Kuś, Mateusz Sawicki, Izabela Dereń-Wagemann, Mariola Sędzimirska, Ugo Giordano, Jarosław Dybko
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2025-06-01
シリーズ:	Biomedicines
主題:	CLL venetoclax rituximab obinutuzumab CD20
オンライン･アクセス:	https://www.mdpi.com/2227-9059/13/7/1609
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!